{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:01:19Z","timestamp":1740106879863,"version":"3.37.3"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2022,10,5]],"date-time":"2022-10-05T00:00:00Z","timestamp":1664928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,10,5]],"date-time":"2022-10-05T00:00:00Z","timestamp":1664928000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001824","name":"Grantov\u00e1 Agentura \u010cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["22-23242S"],"award-info":[{"award-number":["22-23242S"]}],"id":[{"id":"10.13039\/501100001824","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Institute for Research of Metabolic and Cardiovascular Diseases","award":["LX22NPO5104"],"award-info":[{"award-number":["LX22NPO5104"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pflugers Arch - Eur J Physiol"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s00424-022-02757-w","type":"journal-article","created":{"date-parts":[[2022,10,5]],"date-time":"2022-10-05T18:02:47Z","timestamp":1664992967000},"page":"1213-1215","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The omega of TRPM7 channels in trigeminal neuralgia"],"prefix":"10.1007","volume":"474","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0040-1109","authenticated-orcid":false,"given":"Norbert","family":"Weiss","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0644-9066","authenticated-orcid":false,"given":"Gerald W.","family":"Zamponi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,10,5]]},"reference":[{"issue":"Pt 11","key":"2757_CR1","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1113\/jphysiol.2010.186874","volume":"588","author":"SC Cannon","year":"2010","unstructured":"Cannon SC (2010) Voltage-sensor mutations in channelopathies of skeletal muscle. J Physiol 588(Pt 11):1887\u20131895","journal-title":"J Physiol"},{"issue":"8","key":"2757_CR2","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1177\/0333102419897623","volume":"40","author":"G Di Stefano","year":"2020","unstructured":"Di Stefano G, Yuan JH, Cruccu G, Waxman SG, Dib-Hajj SD, Truini A (2020) Familial trigeminal neuralgia - a systematic clinical study with a genomic screen of the neuronal electrogenisome. Cephalalgia 40(8):767\u2013777","journal-title":"Cephalalgia"},{"key":"2757_CR3","doi-asserted-by":"publisher","first-page":"120101","DOI":"10.1016\/j.jns.2021.120101","volume":"434","author":"PK Eide","year":"2022","unstructured":"Eide PK (2022) Familial occurrence of classical and idiopathic trigeminal neuralgia. J Neurol Sci 434:120101","journal-title":"J Neurol Sci"},{"key":"2757_CR4","doi-asserted-by":"publisher","first-page":"174480692090189","DOI":"10.1177\/1744806920901890","volume":"16","author":"E Gambeta","year":"2020","unstructured":"Gambeta E, Chichorro JG, Zamponi GW (2020) Trigeminal neuralgia: an overview from pathophysiology to pharmacological treatments. Mol Pain 16:1744806920901890","journal-title":"Mol Pain"},{"key":"2757_CR5","doi-asserted-by":"publisher","unstructured":"Gambeta E, Gandini MA, Souza IA, Zamponi GW (2022) Cav3.2 calcium channels contribute to trigeminal neuralgia. Pain.\u00a0https:\/\/doi.org\/10.1097\/j.pain.0000000000002651","DOI":"10.1097\/j.pain.0000000000002651"},{"issue":"1","key":"2757_CR6","doi-asserted-by":"publisher","first-page":"e550","DOI":"10.1212\/NXG.0000000000000550","volume":"7","author":"R Gualdani","year":"2021","unstructured":"Gualdani R, Yuan JH, Effraim PR, Di Stefano G, Truini A, Cruccu G, Dib-Hajj SD, Gailly P, Waxman SG (2021) Trigeminal neuralgia trpm8 mutation: enhanced activation, basal [ca2+]I and menthol response. Neurol Genet 7(1):e550","journal-title":"Neurol Genet"},{"issue":"1","key":"2757_CR7","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1093\/neuros\/nyx636","volume":"84","author":"RH Jani","year":"2019","unstructured":"Jani RH, Hughes MA, Gold MS, Branstetter BF, Ligus ZE, Sekula RF (2019) Trigeminal nerve compression without trigeminal neuralgia: intraoperative vs imaging evidence. Neurosurgery 84(1):60\u201365","journal-title":"Neurosurgery"},{"issue":"3","key":"2757_CR8","doi-asserted-by":"publisher","first-page":"E553","DOI":"10.1093\/neuros\/nyz048","volume":"85","author":"P Magown","year":"2019","unstructured":"Magown P, Ko AL, Burchiel KJ (2019) The spectrum of trigeminal neuralgia without neurovascular compression. Neurosurgery 85(3):E553\u2013E559","journal-title":"Neurosurgery"},{"key":"2757_CR9","doi-asserted-by":"publisher","first-page":"174480692110161","DOI":"10.1177\/17448069211016139","volume":"17","author":"MA Mannerak","year":"2021","unstructured":"Mannerak MA, Lashkarivand A, Eide PK (2021) Trigeminal neuralgia and genetics: a systematic review. Mol Pain 17:17448069211016140","journal-title":"Mol Pain"},{"key":"2757_CR10","doi-asserted-by":"publisher","first-page":"338","DOI":"10.2119\/molmed.2016.00131","volume":"22","author":"BS Tanaka","year":"2016","unstructured":"Tanaka BS, Zhao P, Dib-Hajj FB, Morisset V, Tate S, Waxman SG, Dib-Hajj SD (2016) A gain-of-function mutation in nav1.6 in a case of trigeminal neuralgia. Mol Med 22:338\u2013348","journal-title":"Mol Med"},{"issue":"8","key":"2757_CR11","doi-asserted-by":"publisher","first-page":"E1877","DOI":"10.3390\/ijms20081877","volume":"20","author":"ZG Zou","year":"2019","unstructured":"Zou ZG, Rios FJ, Montezano AC, Touyz RM (2019) Trpm7, magnesium, and signaling. Int J Mol Sci 20(8):E1877","journal-title":"Int J Mol Sci"}],"container-title":["Pfl\u00fcgers Archiv - European Journal of Physiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00424-022-02757-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00424-022-02757-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00424-022-02757-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,14]],"date-time":"2022-11-14T17:06:42Z","timestamp":1668445602000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00424-022-02757-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,5]]},"references-count":11,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2757"],"URL":"https:\/\/doi.org\/10.1007\/s00424-022-02757-w","relation":{},"ISSN":["0031-6768","1432-2013"],"issn-type":[{"type":"print","value":"0031-6768"},{"type":"electronic","value":"1432-2013"}],"subject":[],"published":{"date-parts":[[2022,10,5]]},"assertion":[{"value":"26 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"G.W.Z. is Chief Scientific Officer of Zymedine Therapeutics.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"N.W. has no competing interests to declare. G.W.Z. is Chief Scientific Officer of Zymedine Therapeutics.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}]}}